114 related articles for article (PubMed ID: 7640218)
1. Prognostic value of bcl-2 expression in invasive breast cancer.
Hellemans P; van Dam PA; Weyler J; van Oosterom AT; Buytaert P; Van Marck E
Br J Cancer; 1995 Aug; 72(2):354-60. PubMed ID: 7640218
[TBL] [Abstract][Full Text] [Related]
2. Breast Cancer Chemoresistance: Insights into the Regulatory Role of lncRNA.
Ahmadpour ST; Orre C; Bertevello PS; Mirebeau-Prunier D; Dumas JF; Desquiret-Dumas V
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958880
[TBL] [Abstract][Full Text] [Related]
3. Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.
Shamis SA; Savioli F; Ammar A; Al-Badran SS; Hatthakarnkul P; Leslie H; Mallon EE; Jamieson NB; McMillan DC; Edwards J
Histol Histopathol; 2024 Feb; 39(2):177-200. PubMed ID: 37681672
[TBL] [Abstract][Full Text] [Related]
4. Effects of neoadjuvant therapies on genetic regulation of targeted pathways in ER+ primary ductal breast carcinoma: A meta-analysis of microarray datasets.
Albogami SM; Asiri Y; Asiri A; Alnefaie AA; Alnefaie S
Saudi Pharm J; 2021 Jul; 29(7):656-669. PubMed ID: 34400859
[TBL] [Abstract][Full Text] [Related]
5. Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway.
Luo F; Lu FT; Qiu MZ; Zhou T; Ma WJ; Luo M; Zeng KM; Luo QY; Pan WT; Zhang L; Xia ZF; Zhang ZH; Cao JX; Zhao HY; Zhang L; Yang DJ
Cell Death Dis; 2021 Aug; 12(8):772. PubMed ID: 34354046
[TBL] [Abstract][Full Text] [Related]
6. Combined p53 and Bcl2 Immunophenotypes in Prognosis of Vietnamese Invasive Breast Carcinoma: A Single Institutional Retrospective Analysis.
Van Nguyen C; Nguyen QT; Vu HTN; Phung HT; Pham KH; Le RD
Technol Cancer Res Treat; 2020; 19():1533033820983081. PubMed ID: 33357134
[TBL] [Abstract][Full Text] [Related]
7. Bcl-2/Bcl-xl inhibitor APG-1252-M1 is a promising therapeutic strategy for gastric carcinoma.
Yi H; Qiu MZ; Yuan L; Luo Q; Pan W; Zhou S; Zhang L; Yan X; Yang DJ
Cancer Med; 2020 Jun; 9(12):4197-4206. PubMed ID: 32346976
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 expression and prognostic significance in feline invasive mammary carcinomas: a retrospective observational study.
Dagher E; Abadie J; Loussouarn D; Fanuel D; Campone M; Nguyen F
BMC Vet Res; 2019 Jan; 15(1):25. PubMed ID: 30630524
[TBL] [Abstract][Full Text] [Related]
9. Peripheral inflammation/immune indicators of chemosensitivity and prognosis in breast cancer patients treated with neoadjuvant chemotherapy.
Qian Y; Tao J; Li X; Chen H; Lu Q; Yang J; Pan H; Wang C; Zhou W; Liu X
Onco Targets Ther; 2018; 11():1423-1432. PubMed ID: 29588597
[TBL] [Abstract][Full Text] [Related]
10. Determination of the Relative Efficacy of Eicosapentaenoic Acid and Docosahexaenoic Acid for Anti-Cancer Effects in Human Breast Cancer Models.
VanderSluis L; Mazurak VC; Damaraju S; Field CJ
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29207553
[TBL] [Abstract][Full Text] [Related]
11. BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer.
Eom YH; Kim HS; Lee A; Song BJ; Chae BJ
J Breast Cancer; 2016 Sep; 19(3):252-260. PubMed ID: 27721874
[TBL] [Abstract][Full Text] [Related]
12. Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis.
Li P; Guo Y; Bledsoe G; Yang Z; Chao L; Chao J
Exp Cell Res; 2016 Jan; 340(2):305-14. PubMed ID: 26790955
[TBL] [Abstract][Full Text] [Related]
13. Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy.
Honma N; Horii R; Ito Y; Saji S; Younes M; Iwase T; Akiyama F
BMC Cancer; 2015 Oct; 15():698. PubMed ID: 26472348
[TBL] [Abstract][Full Text] [Related]
14. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
Raha P; Thomas S; Thurn KT; Park J; Munster PN
Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
[TBL] [Abstract][Full Text] [Related]
15. Blood vessel invasion and other variables as predictors of long-term survival in Japanese and British patients with primary invasive breast cancer.
Kato T; Pezzella F; Steers G; Campo L; Leek RD; Turley H; Kameoka S; Nishikawa T; Harris AL; Gatter KC; Fox S
Int J Clin Exp Pathol; 2014; 7(11):7967-78. PubMed ID: 25550840
[TBL] [Abstract][Full Text] [Related]
16. Trop-2 is a determinant of breast cancer survival.
Ambrogi F; Fornili M; Boracchi P; Trerotola M; Relli V; Simeone P; La Sorda R; Lattanzio R; Querzoli P; Pedriali M; Piantelli M; Biganzoli E; Alberti S
PLoS One; 2014; 9(5):e96993. PubMed ID: 24824621
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the potent prognostic factors in luminal-type breast cancer.
Kim HS; Park I; Cho HJ; Gwak G; Yang K; Bae BN; Kim KW; Han S; Kim HJ; Kim YD
J Breast Cancer; 2012 Dec; 15(4):401-6. PubMed ID: 23346168
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of p53 and bcl-2 expression in patients treated with breast conservative therapy.
Kim K; Chie EK; Han W; Noh DY; Park IA; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
J Korean Med Sci; 2010 Feb; 25(2):235-9. PubMed ID: 20119576
[TBL] [Abstract][Full Text] [Related]
19. AT-101, a small molecule inhibitor of anti-apoptotic Bcl-2 family members, activates the SAPK/JNK pathway and enhances radiation-induced apoptosis.
Zerp SF; Stoter R; Kuipers G; Yang D; Lippman ME; van Blitterswijk WJ; Bartelink H; Rooswinkel R; Lafleur V; Verheij M
Radiat Oncol; 2009 Oct; 4():47. PubMed ID: 19852810
[TBL] [Abstract][Full Text] [Related]
20. Role of Foxa1 in regulation of bcl2 expression during oxidative-stress-induced apoptosis in A549 type II pneumocytes.
Song L; Wei X; Zhang B; Luo X; Liu J; Feng Y; Xiao X
Cell Stress Chaperones; 2009 Jul; 14(4):417-25. PubMed ID: 19127412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
